Team

Founder & Chair

Arezou A. Ghazani, MSc, PhD, DABMGG, FACMG

Dr. Ghazani is a medical geneticist and scientist with expertise in clinical and molecular genomics, constitutional cancer, tumorigenesis, and precision oncology. She has led the development of several programs and genomic tools and methods to identify actionable genetic alterations in cancer. Emphasis is on using an integrated approach in the evaluation of somatic (tumor) and germline (constitutional) genomic data to inform the role of germline alterations and their effect on the clinical management of cancer patients.

Her passion for bridging scientific advances with current clinical needs led to the establishment and development of INT²GRATE Programs and INT²GRATE Consortium. INT²GRATE Programs leverage tumor-derived signature profiles and clinical genetic information to identify clinically actionable germline alterations in cancer patients. INT²GRATE Consortium is a multi-institutional initiative aimed to share INT²GRATE variant evidence in public databases. Dr. Ghazani serves as the Director of the INT²GRATE Programs and Chair of the INT²GRATE Consortium.

Huma Q. Rana, MD, MPH

Anu Chittenden, MS, LGC

Diane Koeller, MS, MPH, LGC

Alison Schwartz

Levine, MS, LGC

Clinical Genetics

Computational Engineer

McKenzie Walker, BA

Bioinformatian

Connor Hayes, MS

Data Curator

Busra Unal, MD

Data Science

Data Scientist

Monica Devi Manam, MS

Judy E. Garber, MD, MPH

Medical Oncology

Jason L. Hornick, MD, PhD

Mark S. Redston, MD

Justine A. Barletta, MD

Raymond A. Isidro, MD, PhD

Surgical Pathology

See the full list of

Institutional Members